Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports
Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 billion, the Financial…
Echtzeit-Aktienkurs Eli Lilly & Co.
Bid:
Ask:
Nachrichten zur Eli Lilly & Co. Aktie
Why Novo Nordisk Stock Sank by Nearly 4% Today
Novo Nordisk (NYSE: NVO) stock had a Monday to forget, as news from a top rival dampened sentiment on the…
Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts
In the closing of the recent trading day, Eli Lilly (LLY) stood at $807.58, denoting a -1.44% move from the…
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Youre unlikely to have a warm-and-fuzzy feeling after buying some stocks. Instead, some stocks can keep you awake at night…
Eli Lilly Just Made Another Move to Dominate the Weight Loss Market: Should You Buy the Stock?
Eli Lilly (NYSE: LLY) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following recent clinical…
1 Growth Stock Down 9% to Buy Right Now
Not many companies that have been around since the late 1800s can claim that theyre growth companies. But Eli Lilly…
Top Analyst Reports for Eli Lilly, Home Depot & SAP
Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company, The Home Depot and…
Down 12%, Should You Buy the Dip on Eli Lilly? @themotleyfool #stocks $LLY
…
Is This Stock a Buy After Acquiring a Potential Zepbound Competitor?
Shares of Regeneron (NASDAQ: REGN) have declined this year due to issues with one of its former growth drivers, Eylea,…
2 Unstoppable Stocks to Consider Buying, Even Amid Market Volatility
Broader equities have not performed particularly well in 2025. The S&P 500 is barely in the black year to date.…
Should You Buy Eli Lilly Stock Before June 22? @themotleyfool #stocks $LLY
…
Drug pricing reform talks with US government lack clarity, industry executives say
Talks with the Trump administration about lowering U.S. drug prices have so far not provided clarity on when and how…
1 Stock Down 34% This Year to Buy and Hold
Shares of Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech, are down by 34% this year. This poor performance may suggest…
Billionaire Stanley Druckenmiller Has Unloaded Shares of Last Years 2 Top Performing AI Stocks and Is Piling Into a Growth Stock That Has Climbed 150% in 3 Years
You dont have to be a billionaire to invest like one -- and reap the rewards. Any of us can…
Should You Invest $1,000 in Eli Lilly today? @themotleyfool #stocks $LLY $NVO $AMZN $GS $NVDA
…
Should You Invest $1,000 in Eli Lilly today?
Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. The…
Eli Lilly: Mit Milliardenprojekt in Deutschland auf Expansionskurs
Eli Lilly gehört zu den traditionsreichsten Pharmaunternehmen der USA und hat sich in den vergangenen Jahren verstärkt auf wachstumsstarke Bereiche…
Eli Lilly, Camurus in major deal to develop obesity, diabetes drugs
…
Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins
· Partnership focused on development of long-acting therapies based on Camurus’ FluidCrystal[®] technology and Eli Lilly’s proprietary drug compounds
…
Could Viking Therapeutics Become the Next Eli Lilly?
The obesity treatment market is booming, with groundbreaking drugs like Eli Lillys (NYSE: LLY) Zepbound delivering transformative patient results and…
Weight Loss Drug ETF (THNR) Hits New 52-Week High
THNR hits a 52-week high, fueled by gains in Eli Lilly and Novo Nordisk -- could the rally still have…
Key deals this week: EOG Resources, VivoPower, Servotronics, Eli Lilly and more
…
2 Top Stocks to Buy With Less Than $100
When investing on a budget, buying fractional shares of top companies is one option. Another is to find stocks with…
3 American Growth Giants to Invest in for the Long Haul
Many of the best growth stocks in the world are based out of the U.S. This is the land of…
2 Beaten-Down Stocks to Buy on the Dip
It wont come as a surprise to anyone to hear that quite a few quality stocks have performed terribly this…
Eli Lilly to Expand Pain Pipeline With $1B SiteOne Buyout Offer
LLY inks $1B deal to acquire SiteOne, adding phase II-ready pain drug STC-004 to strengthen its neuroscience pipeline.…
Eli Lilly greift nach Zukunft der Schmerzmedizin! SiteOne Therapeutics Deal soll Opioid-Alternativen vorantreiben!
Der Pharmariese Eli Lilly (LLY) übernimmt laut einer Pressemitteilung vom Dienstag, den 27. Mai 2025, das Privatunternehmen SiteOne Therapeutics und…
Eli Lilly vs. AstraZeneca: Which Pharma Powerhouse is the Better Buy?
Lilly dominates GLP-1 market but faces near-term headwinds, while AstraZeneca boasts steady growth, rising estimates and a higher dividend yield.…
Eli Lilly to buy SiteOne for $1 billion with eye on non-opioid pain drug
Eli Lilly will buy privately held SiteOne Therapeutics in a deal worth as much as $1 billion, the companies said…
Eli Lilly expands neuroscience pipeline with $1B acquisition of SiteOne therapeutics
Eli Lilly and Co (NYSE:LLY) announced it is acquiring SiteOne Therapeutics, a private biotech firm developing small-molecule inhibitors of sodium…
Eli Lilly expands neuroscience pipeline with $1B SiteOne acquisition
Eli Lilly and Co (NYSE:LLY) announced it is acquiring SiteOne Therapeutics, a private biotech firm developing small-molecule inhibitors of sodium…
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics By Investing.com
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics…
Prediction: These 2 Stocks Will Beat the Market in the Next Decade
Investors typically want to beat the market over the long run. Though its not an easy task, it certainly is…
Investing for the Long Term: 1 Unstoppable Vanguard ETF to Buy and Hold Forever
The Vanguard Growth ETF (NYSEMKT: VUG) is an exchange-traded fund (ETF) that exclusively holds large-cap stocks. It has outperformed the…
Top Analyst Reports for Eli Lilly, GE Aerospace & Amgen
Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), GE Aerospace (GE)…
Cigna takes different approach with GLP-1s, more favorable for Eli Lilly By Investing.com
Cigna takes different approach with GLP-1s, more favorable for Eli Lilly…
Cigna’s $200 Weight-Loss Drug Cap Shakes Up Hims & Hers Stock
Hims & Hers Health Inc. (HIMS) declined 4.45% to $55.50, with an intraday low of $51.20, as Cigna’s (CI) Evernorth…
Better Weight Loss Stock: Amgen or Viking Therapeutics?
Investors looking to cash in on the fast-growing market for weight management medicines will naturally turn to the two leaders…
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Cignas pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.…
Great News for Eli Lilly Stock Investors!
Eli Lilly (NYSE: LLY) is encouraged by trial data for its latest weight-loss and diabetes medications.
Where to invest $1,000 right…
Novo Nordisk is betting on a CEO shake-up to regain its weight loss drug edge over Eli Lilly
Novo Nordisks new top executive will need to help the company close the gap with Eli Lilly, fend off emerging…
Amid US investment push, Lilly eyes Houston as potential home for $5.9B API plant
With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out potential…
Huge News for Eli Lilly Stock Investors!
Eli Lilly (NYSE: LLY) has a strong pipeline of new medicines that could increase the stock price.
*Stock prices used were…
Why Is Eli Lilly Stock Crashing and Is It a Buying Opportunity?
Eli Lilly (NYSE: LLY) is gaining market share in a lucrative market that could be a catalyst for a stock…
Huge News for Eli Lilly Stock Investors!
Eli Lilly (NYSE: LLY) has a strong pipeline of new medicines that could increase the stock price.…
Zepbound, Mounjaro sales buoy Eli Lilly family endowment
…
Eli Lilly: Obesity Drug Development To Go Beyond That Of Zepbound
…
Weight-Loss Drug Craze Boosts $80 Billion Lilly Endowment to Largest in US
The endowment started by the founding family of drugmaker Eli Lilly saw its assets surge to $80 billion at the end of 2024, passing Bill…
Trumps EO Targets Big Pharma Stocks like Eli Lilly
Trumps order looking to cut prescription drug prices is bearish for drug stocks at the surface, but is the worst…
2 Monster Stocks in the Making to Buy Now and Hold for 10 Years
Investing in promising companies before their stock prices soar is an excellent recipe for earning life-changing returns. However, with hundreds…